Cassava’s Data on Simufilam Looks Promising—Experts Say Too Soon to Know
Cassava Sciences revealed positive clinical data from their simufilam trial, a potentially disease-modifying therapy for treating Alzheimer’s. Their preliminary study showed that simufilam significantly…